Trial Profile
Clinical Study to Assess the Pharmacokinetic Interaction Between CKD-501 and Sulfonylurea (Glimepiride) in Healthy Male Subjects: Single-blinded, Randomized, Crossover Study.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Dec 2010
Price :
$35
*
At a glance
- Drugs Glimepiride (Primary) ; Lobeglitazone (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Acronyms CKD-501 DDI
- 09 Dec 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 03 Jun 2010 New trial record